# LifeShare Blood Center – FDA Inspection, Aug 9, 2019

Source: https://www.keypedia.com/records/fda_inspections/lifeshare-blood-center/66a7889e-019e-40ad-be00-882e82878b55
Source feed: FDA_Inspections

> FDA inspection 1099613 of LifeShare Blood Center, August 09, 2019. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR parts 211, 606 and 630. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1099613
- Company Name: LifeShare Blood Center
- Inspection Date: 2019-08-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1282272 - 2025-08-21](https://www.keypedia.com/records/fda_inspections/lifeshare-blood-center/117f2e7e-d48e-4cc5-acd5-0999bad39c20)
- FDA Inspection 1221056 - 2023-08-31
- FDA Inspection 1017432 - 2017-05-23
- FDA Inspection 936770 - 2015-07-30
- FDA Inspection 754754 - 2011-11-17

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/decarlos-a-gomez/4b003235-edbb-4cb5-acb1-4e154941578c)

Company: https://www.keypedia.com/companies/lifeshare-blood-center/22969067-74a4-4946-be29-9ee8ba7161c2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
